Javier García, Co-Founder of Columbus Venture Partners, worked for 25 years at Eli Lilly and Company, where he held various executive positions in Business Development and Information Systems. Since 2009, he has focused on venture capital investment, particularly in private companies in the biopharmaceutical, life sciences, and medical technology sectors.

He serves on the board of several biotechnology companies, including Highlight Therapeutics, Vivet Therapeutics, Viralgen Vector Core (as Chairman), Cocoon Therapeutics, Syngoi, and NeRRE.

He is also the Founder and Secretary of the Columbus Foundation, which is dedicated to the development of advanced therapies for ultra-rare diseases. He is a trustee of the National Alliance for Hispanic Health and the Healthy Americas Foundation, both based in Washington DC. Additionally, he is a trustee of the Querer Foundation.

Javier García has a Bachelor’s degree in Mathematics (Statistics and Operations Research) from the Complutense University of Madrid and studied an MBA at ICADE (Spain). He is the Tambor de Oro 2023 of the City of San Sebastian.